X
Alzheimer’s disease is now considered to form a continuum, encompassing pathological preclinical changes, mild cognitive impairment (MCI) and AD dementia. How might this change AD diagnosis and management?
New diagnostic technologies have to potential to detect Alzheimer’s disease at an earlier stage. Explore the latest research and what this may mean for patient management.
The neuropathology of Alzheimer’s disease remains an unresolved topic. Unravel the latest findings and controversies with the experts and gain insight into future research directions.
Explore biomarker testing
As we learn more about Alzheimer’s disease, the way we diagnose and manage the condition is likely to change. Discover innovative ways Australians are preparing for the challenges that lie ahead.
ADBioHub brings you exclusive news, views and insights from Australia’s leading Alzheimer’s experts. Stay up to date with our latest content, including webinars, podcasts, articles and videos.
For Australian-registered Healthcare Professionals.
Questions? Contact our Medical Team at adbiohub@biogen.com
